RBC Capital Adds 'Speculative Risk' Qualifier to Concordia (CXRX) Rating, PT Cut to $14
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 4/25/2024
- S&P 500 ends higher as markets weigh rising yields, upbeat corporate results
- Meta Platforms reports softer Q2 revenue guidance on plans to boost spending on AI
- IBM (IBM) announces mixed Q1 results, HashiCorp acquisition; shares down
- Equities mixed as investors eye earnings; yen on intervention watch
- ServiceNow (NOW) stock falls as refreshed subscription outlook trails estimates
- Meta Platforms (META) Tops Q1 EPS by 39c, Offers Guidance
- Hasbro (HAS) brand strength sees earnings top expectations
- IBM (IBM) announces mixed Q1 results, HashiCorp acquisition; shares down
- Seagate Technology (STX) Enters $600M Asset Purchase Agreement with Avago
- Crude Inventory Declined 6.4 Million Barrels Last Week
- After-hours movers: Meta, Ford, IBM, ServiceNow and more
- Midday movers: Tesla, Boeing rise; Uber, Old Dominion Freight fall
- After-hours movers: Tesla, Texas Instruments, Seagate, Visa and more
- Midday movers: PepsiCo, JetBlue fall; GM, Danaher and UPS rise
- After-hours movers: Cadence Design Systems, Cleveland-Cliffs, Riot Platforms, and more
Canaccord Genuity Downgrades Concordia Healthcare (CXRX) to Spec. Buy
September 16, 2016 2:52 PM EDTCanaccord Genuity downgraded Concordia Healthcare (NASDAQ: CXRX) from Buy to Spec. Buy with a price target of $10.00.
For an analyst ratings summary and ratings history on Concordia Healthcare click here. For more ratings news on Concordia Healthcare click here.
Shares of Concordia Healthcare closed at $6.61 yesterday.
... MoreConcordia International (CXRX) Says It's Monitoring Health Service Medical Supplies (Costs) Bill
September 16, 2016 10:03 AM EDTConcordia International Corp. (NASDAQ: CXRX today commented on the UK's Health Service Medical Supplies (Costs) Bill, which was introduced into the House of Commons on September 15, 2016. The proposed bill would amend and extend existing provisions of the National Health Service Act 2006 to help manage the cost of health service medicines.
"Concordia is supportive of... More
Concordia International (CXRX) Under Heavy Pressure Amid Proposed UK Drug Price Bill
September 16, 2016 9:37 AM EDTConcordia International (NASDAQ: CXRX) slammed which is attributed to a new proposed UK bill to control drug prices. Shares down 13.8%.
... More
